NASDAQ: CNTX
Context Therapeutics Inc Stock Ownership - Who owns Context Therapeutics?

Insider buying vs selling

Have Context Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Martin A. LehrChief Executive Officer2025-06-09100,000$0.70
$70.10kBuy
Alex C. LevitChief Legal Officer Corp. Sec2025-06-0620,000$0.58
$11.52kBuy
Jennifer Lynn MinaiazaryChief Financial Officer2025-06-0640,010$0.64
$25.49kBuy

1 of 1

CNTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CNTX insiders and whales buy or sell their stock.

CNTX Shareholders

What type of owners hold Context Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Mpm Bioimpact LLC16.39%14,705,882$12.47MInstitution
Avidity Partners Management LP8.34%7,477,255$6.34MInstitution
Nextech Invest Ltd8.27%7,419,355$6.29MInstitution
Deep Track Capital LP8.27%7,419,355$6.29MInstitution
Blue Owl Capital Holdings LP8.26%7,407,906$6.28MInstitution
Great Point Partners LLC5.22%4,683,711$3.97MInstitution
Franklin Resources Inc4.46%4,003,380$3.39MInstitution
Vanguard Group Inc3.75%3,360,582$2.85MInstitution
Blackstone Inc2.72%2,440,330$2.07MInstitution
Nantahala Capital Management LLC2.16%1,935,484$1.64MInstitution

1 of 3

CNTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CNTX76.50%1.46%Net Buying
IMUX52.37%16.57%Net Buying
IFRX24.81%0.00%
OKYO0.50%99.50%
ENTX22.47%16.68%Net Buying

Context Therapeutics Stock Ownership FAQ

Who owns Context Therapeutics?

Context Therapeutics (NASDAQ: CNTX) is owned by 76.50% institutional shareholders, 1.46% Context Therapeutics insiders, and 22.04% retail investors. Martin A. Lehr is the largest individual Context Therapeutics shareholder, owning 1.08M shares representing 1.20% of the company. Martin A. Lehr's Context Therapeutics shares are currently valued at $944.90k.

If you're new to stock investing, here's how to buy Context Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.